Elanco Animal Health Incorporated
NYSE: ELAN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Jeffrey N. Simmons
- Employees
- 9,000
- Headquarters
- Greenfield, United States
- IPO year
- 2018
- Market cap
- $12.0B
- Website
- https://www.elanco.com
Loading ELAN…
Loading profile data…Frequently asked questions about ELAN
What does Elanco Animal Health Incorporated (ELAN) do?
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, an...
Where does ELAN trade?
Elanco Animal Health Incorporated (ELAN) trades on the New York Stock Exchange.
What sector is ELAN in?
Elanco Animal Health Incorporated (ELAN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Elanco Animal Health Incorporated?
Jeffrey N. Simmons is the chief executive officer of Elanco Animal Health Incorporated (ELAN).
Where is Elanco Animal Health Incorporated headquartered?
Elanco Animal Health Incorporated is headquartered in United States.
Does ELAN pay a dividend?
Elanco Animal Health Incorporated (ELAN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ELAN go public?
Elanco Animal Health Incorporated (ELAN) completed its initial public offering in 2018.